Last quarter (Q ), Silo Pharma's total revenue was $111.54K, an increase of 518.80% from the same quarter last year. In Q, Silo Pharma's net income was $-1.02M. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 98.12K	$ -279.73K	$ 7.00M	$ 0.00	$ 40.57K	$ 0.00
Cost of Revenue	$ 1.46K	-	-	$ 0.00	$ 27.39K	$ 0.00
Gross Profit	$ 16.57K	-	-	$ 0.00	$ 13.18K	$ 0.00
Operating Expense	$ 965.72K	-	-	$ 2.04M	$ 927.64K	$ 459.83K
Operating Income	$ -949.15K	-	-	$ -2.04M	$ -914.46K	$ -459.83K
Net Non Operating Interest Income Expense	$ 981.00	-	-	$ -257.72K	$ -50.73K	$ 4.22K
Other Income Expense	$ -35.07K	-	-	$ -372.20K	$ -48.10K	$ -513.85K
Pretax Income	$ -2.92M	$ -3.91M	$ 3.88M	$ -2.67M	$ -1.01M	$ -969.46K
Tax Provision	$ 906.40K	$ -254.06K	$ 24.88K	$ 0.00	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -5.46M	$ -4.02M	$ 2.20M	$ -3.11M	$ -1.01M	$ -969.46K
Basic EPS	$ 983.24K	$ -1.71	$ 2.00	$ -0.05	$ -0.04	$ -0.02
Diluted EPS	$ -2.81	$ -1.71	$ 2.00	$ -0.05	$ -0.04	$ -0.02
Basic Average Shares	$ 10.60M	$ 2.28M	$ 1.90M	$ 65.95M	$ 23.47M	$ 49.10M
Diluted Average Shares	$ 10.60M	$ 2.28M	$ 1.92M	$ 65.95M	$ 23.47M	$ 49.10M
Dividend Per Share	$ 0.49	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 967.18K	-	-	$ 2.04M	$ 955.03K	$ 459.83K
Net Income From Continuing And Discontinued Operation	$ -4.00M	$ -3.91M	$ 3.61M	$ -3.04M	$ -1.01M	$ -969.46K
Normalized Income	$ -1.75M	$ -4.16M	-	$ -2.29M	$ -965.20K	$ -455.61K
Interest Expense	$ -1.99K	$ 2.20K	$ 3.04K	$ 269.27K	$ 62.93K	$ 0.00
EBIT	$ -1.87M	-	$ 3.88M	$ -2.40M	$ -950.37K	$ -969.46K
EBITDA	$ -1.87M	-	$ 3.88M	$ -2.40M	$ -950.37K	$ -951.91K

Currency in USD

Silo Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing